Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Add To Watchlist

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Reports Record Third Quarter and Year-To-Date 2017 Results and Narrows Full Year Guidance

PR Newswire November 2, 2017

Report: Developing Opportunities within Echelon, NII Holdings, ANI Pharmaceuticals, Zion Oil & Gas, vTv Therapeutics, and Sears Holdings – Future Expectations, Projections Moving into 2018

GlobeNewswire November 2, 2017

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2017 Financial Results

PR Newswire October 26, 2017

Wall Street's M&A Chatter From October 13-15: T-Mobile-Sprint, Radius Health, ANI Pharmaceuticals

Benzinga.com October 16, 2017

ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL

PR Newswire September 1, 2017

ANI Pharmaceuticals to Present at the Canaccord Genuity 37th Annual Growth Conference

PR Newswire August 8, 2017

ANI Pharmaceuticals Reports Record Second Quarter and Year-To-Date 2017 Results and Reaffirms Guidance

PR Newswire August 3, 2017

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2017 Financial Results

PR Newswire July 27, 2017

Options trade ideas for ANI Pharmaceuticals, Facebook, Gilead Sciences, Hilton Worldwide and Shutterfly offer returns of 21% or more!

PR Newswire July 26, 2017

ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets

PR Newswire June 20, 2017

ANI Pharmaceuticals Announces Launch of Pindolol Tablets

PR Newswire May 8, 2017

ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2017 Highlights and Reaffirms Guidance

PR Newswire May 4, 2017

Investor Network: ANI Pharmaceuticals, Inc. to Host Earnings Call

Accesswire May 4, 2017

ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2017 Financial Results

PR Newswire April 27, 2017

20 Biggest Mid-Day Losers For Thursday

Benzinga.com March 2, 2017

ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance

PR Newswire March 2, 2017

ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®

PR Newswire February 24, 2017

ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2016 Financial Results and 2017 Guidance

PR Newswire February 16, 2017

ANI Announces Appointment of Karen Quinn Ph.D as Vice President Corticotropin Regulatory Affairs

PR Newswire January 17, 2017

ANI Pharmaceuticals Announces Launch of Authorized Generic of Lithobid® Extended Release Tablets

PR Newswire December 21, 2016